adenocarcinoma of the cervix
edema
blemish on the skin
hepatocellular carcinoma in the united state
increase risk of invasive breast cancer
clay color stool
combine oral contraceptive on the risk of cervical adenocarcinoma
risk of gallbladder disease
heavy non menstrual vaginal bleeding
cardiovascular
venous thromboembolism
oral contraceptive
case of fatal pulmonary venooclusive disease
itch or rash
irregular heartbeat
increase risk of coronary heart disease
coronary risk
medroxyprogesterone
use of oral contraceptive combination
pulmonary embolism
world health organization committee
association between oral contraceptive use
intrahepatic cholestasis
woman
available oral contraceptive combination
accelerate growth
preexist
available preparation
risk of ovarian cyst
cause favorable change in lipid profile
develop country
manufacturer of oral contraceptive product
gallbladder disease
double vision
arterial thrombosis
association
nausea
early investigation of woman
nervous system
oral contraceptive use
association with oral contraceptive
investigator
risk of epithelial ovarian cancer
breast tenderness
pimple
benefit
oral tablet
well differentiate hepatocellular carcinoma
increase risk of pulmonary embolism
myocardial infarction
geographic tongue
cardiovascular system
cramp
unpleasant breath odor
specific group of woman
tightness in the chest
weak progestin
ovarian cancer
glucose tolerance
skin
public health importance in the united state
possible relationship between the use of oral contraceptive
most woman
fever
unusual warmth
heavy bleeding
pain
incidence of iron deficiency anemia
same committee
arm
depression
vaginal bleeding
change in amount of cervical secretion
first several cycle of oral contraceptive use
older formulation
increase ldl cholesterol level
change in vaginal bleeding pattern
exogenous estrogen
protection against ovarian cancer
vascular thrombosis
risk of ectopic pregnancy
swell in the arm
difficulty with speaking
detailed information
confusion
number of investigation
cause
higher risk for endometrial carcinoma than other woman
short term use of oral contraceptive
leg
neoplasm of the uterine cervix
spot
risk of coronary heart disease
oral capsule liquid
exist cancer
liver cell adenoma
protection
careful review of a woman
case of oral contraceptive induce esophageal ulceration
conception delay
dizziness
increase in size of uterine leiomyomata
severe lipidemia
progestin in a
last
committee of the world health organization
alteration in lipid profile
exogenous progestin
sudden vision change
long term risk for mortality
antiestrogen
use of oral contraceptive
weight change
smoke
epidermoid carcinoma
endometrial cancer
significant blood pressure increase
vaginitis
variation in the hormonal content of oral contraceptive
use of exogenous estrogen
facial muscle
breakthrough bleeding
indigestion
normal menstrual bleeding
cholesterol level
unexpected menstrual bleeding
overall association between oral contraceptive use
rare case of oral contraceptive induce systemic lupus erythematosus
non hormonal cause of such bleeding
dark urine
malignant neoplasm
cardiovascular risk factor before a decision
risk of thromboembolism
stomach pain
flushing of the skin
incidence of hospitalization for pelvic inflammatory disease
ethinyl estradiol
contraindication
experienced several non contraceptive health benefit
investigation into the epidemiology of this neoplasm
unusual tiredness
addition
observe association
change in cervical ectropion
estrogen in oral contraceptive combination
development of new case of cancer
pain in the chest
pelvic inflammatory disease in woman
hepatocellular carcinoma
young woman
change in contact lens tolerance
underlie
precipitation of panic disorder
nulliparous woman
risk of ovarian cancer
insufficient datum
headache
risk of breast cancer
loss of appetite
increase risk
give product
abnormal withdrawal bleeding
mcg
case of venous thrombosis
relative risk of hepatocellular carcinoma
vomiting of blood
other western nation
other risk factor
heavier menstrual period
such woman
chill
anxiety
treated woman
breast cancer
slurred speech
oral contraceptive combination
weak association between long term use of oral contraceptive
n
vomit
bias
yellow eye
strong association between oral contraceptive use
hepatic granuloma
hdl
incidence of pelvic inflammatory disease
groin
estrogen
flow
stroke
development of breast cancer
exist
norethindrone
exist vascular disease
potency of the specific estrogen
long term use
risk of endometrial cancer
redness
family history of breast cancer
severity
inability
menstrual regularity
diarrhea
endometrial carcinoma
chorea
oral contraceptive user
sudden loss of coordination
weakness
finding
woman with a history of previous thrombotic disease
recent large investigation of woman
young diabetic woman
firm conclusion
inability to speak
conjugate equine estrogen
preexist systemic disease
hepatitis b virus infection
focal nodular hyperplasia
large number of confounding factor
irregular menstrual period
underlie cardiovascular disease
woman experience oligomenorrhea
vaginal candidiasis
progestin
relative amount
termination
postmenopausal woman
calf of the leg
thrombotic stroke
possible relationship between oral contraceptive use
endometrial hyperplasia
carbohydrate metabolism
lower risk
hepatic hemangioma
rare case of retinal thrombosis
other investigator
severe nausea
chest pain
amenorrhea
long term use of oral contraceptive
previous thrombotic disease
increase risk of dysplasia
incidence of dysmenorrhea
actual number of case of liver cancer in the united state